You have 9 free searches left this month | for more free features.

J18127 PSMA PyL 18F-DCFPyL PET/CT

Showing 1 - 25 of 9,625

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Active, not recruiting
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    SKCCC
Apr 5, 2022

Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

Not yet recruiting
  • Prostate Cancer
  • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
  • (no location specified)
Jan 26, 2023

Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)

Active, not recruiting
  • Carcinoma of Prostate
  • 18F-DCFPyL
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 31, 2022

Schwannomas, Malignant Tumors Trial in Baltimore (18F-DCFPyL Injection)

Completed
  • Schwannomas
  • Malignant Tumors
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Jan 9, 2023

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Completed
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)

Active, not recruiting
  • Metastatic Prostate Cancer
  • [F-18] DCFPyL
  • PET/CT imaging
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)

Not yet recruiting
  • Prostate Cancer Diagnosis
  • PSMA PET scan
  • +2 more
  • Los Angeles, California
    VA Greater Los Angeles Healthcare System
Apr 20, 2023

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

Recruiting
  • Malignancy
  • Al18F-PSMA-BCH PET/CT
  • Beijing, Chaoyang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023

Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

Enrolling by invitation
  • Prostate Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Prostate Carcinoma Trial in Duarte (procedure, other, device)

Recruiting
  • Prostate Carcinoma
  • Computed Tomography
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Prostatic Tumors Trial in New York (18F- DCFPyL PET/CT)

Active, not recruiting
  • Prostatic Neoplasms
  • 18F- DCFPyL PET/CT
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Prostate Cancer Trial in Québec (Enzalutamide capsule)

Recruiting
  • Prostate Cancer
  • Enzalutamide capsule
  • Québec, Canada
    CHU de Québec-Université Laval
Mar 29, 2022

Prostate Cancer Trial ([18F]-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • [18F]-PSMA-1007
  • (no location specified)
Jan 30, 2023

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)

Recruiting
  • Multiple Myeloma
  • Shenyang, Liaoning, China
    The First Affiliated Hospital of China Medical University
Jul 6, 2022

Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)

Not yet recruiting
  • Prostate Cancer
  • 18F-PSMA-1007 PET/CT based on diagnostic model
  • Hefei, Anhui, China
    The First Affiliated Hospital of USTC
Dec 6, 2022

Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
Oct 18, 2022

Prostate Cancer Trial in Montreal (18F-DCFPyL PET/CT)

Enrolling by invitation
  • Prostate Cancer
  • 18F-DCFPyL PET/CT
  • Montreal, Quebec, Canada
    Jewish General Hospital
May 3, 2022

Prostate Carcinoma Trial in Chicago (Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol)

Not yet recruiting
  • Prostate Carcinoma
  • Fluorine F 18 DCFPyL
  • +6 more
  • Chicago, Illinois
    Northwestern University
Aug 2, 2022

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Withdrawn
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Prostate Cancer Trial in Edmonton (18F-PSMA-1007)

Active, not recruiting
  • Prostate Cancer
  • 18F-PSMA-1007
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 10, 2022